Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. (Q33343921)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. |
scientific article |
Statements
1 reference
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. (English)
1 reference
K Itoh
1 reference
T Ohtsu
1 reference
H Fukuda
1 reference
Y Sasaki
1 reference
M Ogura
1 reference
Y Morishima
1 reference
T Chou
1 reference
K Aikawa
1 reference
N Uike
1 reference
F Mizorogi
1 reference
T Ohno
1 reference
S Ikeda
1 reference
T Sai
1 reference
M Taniwaki
1 reference
F Kawano
1 reference
M Niimi
1 reference
T Hotta
1 reference
M Shimoyama
1 reference
K Tobinai
1 reference
Members of the lymphoma study group of the Japan Clinical Oncology Group (JCOG)
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference